| The development and plasticity of alveolar type 1 cells J Yang, BJ Hernandez, D Martinez Alanis, O Narvaez del Pilar, L Vila-Ellis, ... Development 143 (1), 54-65, 2016 | 159 | 2016 |
| Overexpression of 14-3-3ζ in cancer cells activates PI3K via binding the p85 regulatory subunit CL Neal, J Xu, P Li, S Mori, J Yang, NN Neal, X Zhou, SL Wyszomierski, ... Oncogene, 2011 | 122 | 2011 |
| Y chromosomes of prehistoric people along the Yangtze River H Li, Y Huang, LF Mustavich, F Zhang, JZ Tan, LE Wang, J Qian, MH Gao, ... Human genetics 122 (3), 383-388, 2007 | 68 | 2007 |
| Speckle-type POZ protein, SPOP, is involved in the DNA damage response D Zhang, H Wang, M Sun, J Yang, W Zhang, S Han, B Xu Carcinogenesis 35 (8), 1691-1697, 2014 | 56 | 2014 |
| Upregulation of Neutrophil Gelatinase–Associated Lipocalin by ErbB2 through Nuclear Factor-κB Activation SH Li, VS Hawthorne, CL Neal, S Sanghera, J Xu, J Yang, H Guo, ... Cancer research 69 (24), 9163, 2009 | 43 | 2009 |
| 14-3-3ζ Orchestrates Mammary Tumor Onset and Progression via miR-221–Mediated Cell Proliferation SK Rehman, SH Li, SL Wyszomierski, Q Wang, P Li, O Sahin, Y Xiao, ... Cancer research 74 (1), 363-373, 2014 | 34 | 2014 |
| Developmental programs of lung epithelial progenitors: a balanced progenitor model J Yang, J Chen Wiley Interdisciplinary Reviews: Developmental Biology 3 (5), 331-347, 2014 | 26 | 2014 |
| Identification and characterization of a new member of serpin family-HongrES1 in rat epididymis ZH Hu, Q Liu, Q Shang, M Zheng, J Yang, YL Zhang Cell Research 12 (5), 407-410, 2002 | 24 | 2002 |
| 14-3-3ζ loss impedes oncogene-induced mammary tumorigenesis and metastasis by attenuating oncogenic signaling S Joshi, J Yang, Q Wang, P Li, H Wang, Q Zhang, Y Xiong, BF Pickering, ... American Journal of Cancer Research 7 (8), 1654, 2017 | 15 | 2017 |
| 14-3-3ζ loss leads to neonatal lethality by microRNA-126 downregulation-mediated developmental defects in lung vasculature J Yang, S Joshi, Q Wang, P Li, H Wang, Y Xiong, Y Xiao, jinyang Wang, ... Cell & bioscience 7 (58), 2017 | 13 | 2017 |
| 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types D Yu, J Yao, CL Neal, W Yang, X Zhou, RE Pollock, M Hung, J Yang, P Li, ... US Patent 7,316,907, 2008 | 10 | 2008 |
| 14-3-3 ZETA OVER-EXPRESSION AS A POOR PROGNOSIS FACTOR, AND A THERAPEUTIC TARGET IN MULTIPLE CANCER TYPES D YU, J YAO, C NEAL, W YANG, X ZHOU WO Patent WO/2005/055,925, 2005 | 10 | 2005 |
| Loss of 14-3-3zeta attenuates miR-126 expression and results in neonatal lethality S Joshi, J Yang, Q Wang, P Li, H Wang, B Pickering, Y Xiong, ... Cancer Research 75 (15_Supplement), 2310-2310, 2015 | | 2015 |
| Loss of 14-3-3zeta impairs oncogene-induced mammary tumorigenesis and metastasis. S Joshi, J Yang, Q Wang, P Li, H Wang, B Pickering, Y Xiong, ... Cancer Research 73 (8_Supplement), 2328-2328, 2013 | | 2013 |
| Developmental Deregulation And Tumorigenesis Inhibition In 14-3-3Zeta Knockout Mouse J Yang | | 2011 |
| 14-3-3ζ loss leads to neonatal lethality by microRNA-126 downregulation-mediated developmental defects in lung vasculature | | |
| 14-3-3ζ loss leads to neonatal lethality by microRNA-126 downregulation-mediated developmental defects in lung vasculature | | |
